Immunohistochemistry
Immunohistochemistry is an intervention with 21 clinical trials. Currently 1 active trials ongoing. Historical success rate of 81.8%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
81.8%
9 of 11 finished
18.2%
2 ended early
1
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression
The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients
ALDOA Expression in Bladder Urothelial Carcinoma
The Innate Immune Response and Enteric Nervous System in Crohn's Disease.
Clinical Trials (21)
Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression
The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients
ALDOA Expression in Bladder Urothelial Carcinoma
The Innate Immune Response and Enteric Nervous System in Crohn's Disease.
AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer
Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
Hepatobiliary Tumors Tissue Samples Acquisition
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma
Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions
Brivanib Metastatic Renal Cell Carcinoma
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)
Fibrotic Focus in Breast Cancer
Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer
Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
PACE4 in Thyroid Cancer
GLUT1: A Novel Tool re fl Ecting Proliferative Activity of Lung Neuroendocrine Tumors
Prognostic Value of PD-L1 in NSCLC
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 21